Biomedical Engineering Reference
In-Depth Information
or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label,
randomised controlled trial.
Lancet
, 2010.
376
(9742): 687-697.
166. Berchuck, A.,
, Overexpression of HER-2/neu is associated with
poor survival in advanced epithelial ovarian cancer.
et al.
Cancer Res
, 1990.
(13): 4087-4091.
167. Fajac, A.,
50
, c-erbB2 gene amplification and protein expression in
ovarian epithelial tumors: evaluation of their respective prognostic
significance by multivariate analysis.
et al.
Int J Cancer
, 1995.
64
(2): 146-
151.
168. Felip, E.,
, Overexpression of c-erbB-2 in epithelial ovarian cancer.
Prognostic value and relationship with response to chemotherapy.
Cancer
et al.
(8): 2147-2152.
169. Garcia-Velasco, A.,
, 1995.
75
, Prognostic value of hormonal receptors, p53,
ki67 and HER2/neu expression in epithelial ovarian carcinoma.
et al.
Clin
Transl Oncol
, 2008.
10
(6): 367-371.
170. Hogdall, E.V.,
, Distribution of HER-2 overexpression in ovarian
carcinoma tissue and its prognostic value in patients with ovarian
carcinoma: from the Danish MALOVA Ovarian Cancer Study.
et al.
Cancer
,
(1): 66-73.
171. Kupryjanczyk, J.,
2003.
98
, TP53 status determines clinical significance of
ERBB2 expression in ovarian cancer.
et al.
Br J Cancer
, 2004.
91
(11): 1916-
1923.
172. Lassus, H.,
, ERBB2 amplification is superior to protein expression
status in predicting patient outcome in serous ovarian carcinoma.
Gynecol Oncol
et al.
, 2004.
92
(1): 31-39.
173. Meden, H.,
, Overexpression of the oncogene c-erb B2 in primary
ovarian cancer: evaluation of the prognostic value in a Cox proportional
hazards multiple regression.
et al.
Int J Gynecol Pathol
, 1994.
13
(1): 45-53.
174. Nielsen, J.S.,
, Prognostic significance of p53, Her-2, and EGFR
overexpression in borderline and epithelial ovarian cancer.
et al.
Int J
Gynecol Cancer
, 2004.
14
(6): 1086-1096.
175. Tuefferd, M.,
, HER2 status in ovarian carcinomas: a multicenter
GINECO study of 320 patients.
et al.
PLoS One
, 2007.
2
(11): e1138.
176. Vermeij, J.,
, Genomic activation of the EGFR and HER2-neu genes
in a significant proportion of invasive epithelial ovarian cancers.
et al.
BMC
Cancer
, 2008.
8
: 3.
177. Verri, E.,
, HER2/neu oncoprotein overexpression in epithelial
ovarian cancer: evaluation of its prevalence and prognostic significance.
Clinical study.
et al.
Oncology
, 2005.
68
(2-3): 154-161.
